Egetis Therapeutics AB (publ)

kr 11.12As of Sun 8 Nov 2026, 12:00 UTC
STO:EGTXHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (4.25%)
Div yield —
ROE (152.21%)
Biotechnology
Beta (5Y) 0.81
PE TTM —
TSR TTM 68.48%
Mkt cap kr 5.170B
ROIC (71.43%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 13
17.61%
(49.37%)
Hold 3|10|8|9|5
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.21
0.22
0.21
0.22
18.61%
23.99%
9.53%
7.91%
Revenuekr M
346.4
366.4
358.1
355.4
7.44%
14.97%
8.92%
3.06%
Peers (US$522.7M)
Cap (US$)
PE
156.3M
8.576x
Capital
TTM
5Y
10Y
Leveragex
0.773
0.087
0.059
EBIT/Intx
0.835
0.943
0.955
Own earn%
33.37
1.81
1.63
Sh yield%
34.16
35.70
37.14
Owners
Insiders/Inst%
14.18
45.51
Short interest%
2.81
SBC / revenue%
0.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
19–26
$1 testx
0.0
Incr. ROIC%
−4